In her nearly 20 years at NPR, Tracy Wahl has established herself as a champion for innovation in the newsroom. She was among the first at NPR to embrace social media as a way to engage audiences and deepen our journalism through crowd-sourced reporting. She launched Morning Edition's first Twitter account, and led the program's early ventures into multi-platform storytelling.
In our final episode, we explore Dorothy Andersen’s legacy—what she left behind and how her work has lived on since her death. Describing her mentor’s influence on her life and career, Dr. Celia Ores gives us a rare look into what Dr. Andersen was really like. We then turn to researchers, doctors, and patients, who fill us in on the progress that has grown from Dr. Andersen’s initial work. These major developments include the discovery of the cystic fibrosis gene, the tremendous impact of the drug Trikafta, and the potential of lifesaving gene editing techniques.
When physician and pathologist Dorothy Andersen confronted a slew of confounding infant deaths, she suspected the accepted diagnosis wasn’t right. Her medical sleuthing led to the world’s understanding of cystic fibrosis, a disease that affects the lungs, the pancreas and a host of other organs. But she is by no means a household name. Who was this scientist, and how did she come to quietly make such an important medical contribution? This is the Lost Women of Science podcast
In her nearly 20 years at NPR, Tracy Wahl has established herself as a champion for innovation in the newsroom. She was among the first at NPR to embrace social media as a way to engage audiences and deepen our journalism through crowd-sourced reporting. She launched Morning Edition's first Twitter account, and led the program's early ventures into multi-platform storytelling.